Duke and U-Penn are also doing early clinical trials of T-cell therapies (using HIV and other virii to train the own body's T-cells to identify cancer) and other novel approaches for attacking GBM.

https://www.clinicaltrials.gov/ct2/show/NCT02209376 (Novartis + U-Penn + UC SF)

http://neuro.surgery.duke.edu/research/basic-research/duke-b...